Perioperative nonhormonal pharmacological interventions for bleeding reduction during open and minimally invasive myomectomy: a systematic review and network meta-analysis

To synthesize evidence on the most effective pharmacological interventions for bleeding reduction during open and minimally invasive myomectomy. Systematic review and network meta-analysis of randomized controlled trials (RCTs). Not applicable. Trials assessing efficacy of pharmacological interventi...

Full description

Saved in:
Bibliographic Details
Published in:Fertility and sterility 2020-01, Vol.113 (1), p.224-233.e6
Main Authors: Samy, Ahmed, Raslan, Ayman N., Talaat, Bassem, El Lithy, Ahmed, El Sharkawy, Mohamed, Sharaf, Marwa Fouad, Hussein, Amr Hassan, Amin, Ahmed Hussein, Ibrahim, Ahmed M., Elsherbiny, Wael Sayed, Soliman, Hossam H., Metwally, Ahmed A.
Format: Article
Language:English
Subjects:
Hemorrhage
myomectomy
pharmacological intervention
uterine fibroid
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To synthesize evidence on the most effective pharmacological interventions for bleeding reduction during open and minimally invasive myomectomy. Systematic review and network meta-analysis of randomized controlled trials (RCTs). Not applicable. Trials assessing efficacy of pharmacological interventions during different types of myomectomy. Misoprostol, oxytocin, vasopressin, tranexamic acid (TXA), epinephrine, or ascorbic acid. Intraoperative blood loss and need for blood transfusion. The present review included 26 randomized control trials (RCTs) (N = 1627). For minimally invasive procedures (9 RCTs; 474 patients), network meta-analysis showed that oxytocin (mean difference [MD] −175.5 mL, 95% confidence interval [CI] −30.1.07, −49.93), ornipressin (MD −149.6 mL, 95% CI − 178.22, −120.98), misoprostol, bupivacaine plus epinephrine, and vasopressin were effective in reducing myomectomy blood loss, but the evidence is of low quality. Ranking score of treatments included in subgroup analysis of minimally invasive myomectomy showed that oxytocin ranked first in reducing blood loss, followed by ornipressin. For open myomectomy (17 RCTs; 1,153 patients), network meta-analysis showed that vasopressin plus misoprostol (MD −652.97 mL, 95% CI − 1113.69, −174.26), oxytocin, TXA, and misoprostol were effective; however, the evidence is of low quality. Vasopressin plus misoprostol ranked first in reducing blood loss during open myomectomy (P = .97). There is low-quality evidence to support uterotonics, especially oxytocin, and peripheral vasoconstrictors as effective options in reducing blood loss and need for blood transfusion during minimally invasive myomectomy. Oxytocin is the most effective intervention in minimally invasive myomectomy. For open myomectomy, a combination of uterotonics and peripheral vasoconstrictors is needed to effectively reduce blood loss. Intervención farmacológica periquirúrgica para la reducción del sangrado durante la miomectomía abierta y mínimamente invasiva: una revisión sistemática y metaanálisis en red Sintetizar la evidencia sobre las intervenciones farmacológicas más efectivas para la reducción del sangrado durante la miomectomía abierta y mínimamente invasiva. Revisión sistemática y metaanálisis en red de estudios aleatorizados controlados (RCTs). No aplicable. Estudios que valoran la eficacia de la intervención farmacológica durante distintos tipos de miomectomías. Misoprostol, oxitocina, vasopresina, ácido tranexámico (TXA), adr
ISSN:0015-0282
1556-5653
DOI:10.1016/j.fertnstert.2019.09.016